Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes

Nature Medicine

Volumn 4, Issue 10, 1998, Pages 1185-1188

  Mignon, Alexandra ^a   Guidotti, Jacques E ^a   Mitchell, Claudia ^a   Fabre, Monique ^b   Wernet, Anne ^a   De La Coste, Alix ^a   Soubrane, Olivier ^c   Gilgenkrantz, Helene ^a   Kahn, Axel ^a  

^a INSTITUT COCHIN   (France)

^b BICÊTRE HOSPITAL   (France)

^c Université Paris Descartes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL TRANSPLANTATION; GENETIC ENGINEERING; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL TRANSPLANTATION; CHIMERA; FEMALE; GENES, BCL-2; HUMANS; LIVER; MALE; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; SELECTION (GENETICS);

ANIMALIA; MUS MUSCULUS;

EID: 0031752146     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/2681     Document Type: Article

References (17)

1. Fox, I.J. et al. Brief Report: Treatment of the Crigler-Najjar Syndrome Type I with Hepatocyte Transplantation. N. Engl. J. Med. 338, 1422 (1998).
2. Lake, J.R. Hepatocyte Transplantation. N. Engl. J. Med. 328, 1463 (1998).
3. Sandgren, E.P. et al. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 66, 245-256 (1991).
4. Rhim, J.A., Sandgren, E.P., Degen, J.L., Palmiter, R.D. & Brinster, R.L. Replacement of diseased mouse liver by hepatic cell transplantation. Science 263, 1149-1152 (1994).
5. Rhim, J.A., Sandgren, E.P., Palmiter, R.D. & Brinster, R.L. Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc. Natl. Acad. Sci. USA 92, 4942-4946 (1995).
6. Overturf, K. et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nature Genet. 12, 266-273 (1996).
7. Wilson, J.M. Round two for liver gene therapy. Nature Genet. 12, 232-233 (1996).
8. Lacronique, V. et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Med. 2, 80-86 (1996).
9. Vrancken Peeters, M.J., Patijn, C.A., Lieber, A., Perkins, J. & Kay, M.A. Expansion of donor hepatocytes after recombinant adenovirus-induced liver regeneration in mice. Hepatology 25, 884-888 (1997).
10. Ponder, K.P. et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88, 1217-1221 (1991).
11. Snyder, R.O. et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 16, 270-276 (1997).
12. Kafri, T., Blomer, U., Peterson, D.A., Gage, F.H. & Verma, I.M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genet. 17, 314-317 (1997).
13. Yang, E. & Korsmeyer, S.J. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood 88, 386-401 (1996).
14. Nagata, S. Apoptosis by death factor. Cell 88, 355-365 (1997).
15. Galle, P.R. et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230 (1995).
16. Berry, M.N. & Friend, D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J. Cell. Biol. 43, 506-520 (1969).
17. Sambrook, J., Fritch, E.E. & Maniatis, T. Molecular Cloning : A Laboratory Manual, 2nd edn. (Cold Spring Harbor Laboratory, New York, 1989).